Stay updated on Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page.

Latest updates to the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page
- Check7 days agoChange DetectedA new history entry on 2026-08-06 adds a 'Study Status' field and Revision: v3.6.5, while the 2026-05-01 entry and Revision: v3.6.4 were removed.SummaryDifference0.3%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a platform update reflected in the history record.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe page now shows a new site revision stamp (v3.6.3), replacing the previous v3.6.2, indicating a small platform update to the history view.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, reflecting a newer release of the site's record history viewer. This indicates an update to the page's underlying interface/version rather than study data.SummaryDifference0.1%

- Check64 days agoChange DetectedThe record history shows recruitment has ended (No longer looking for participants) and a new version of the record (v3.6.0) was posted, replacing the earlier revision (v3.5.5).SummaryDifference0.2%

- Check71 days agoChange DetectedThe revision label in the footer changed from v3.5.4 to v3.5.5, indicating a small update to the page's versioning information in the history view.SummaryDifference0.1%

Stay in the know with updates to Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page.